Bioleaders Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioleaders Corp with three other
companies in this sector in South Korea:
sales of 94.52 billion Korean Won [US$78.93 million]
of which 18%
was Health Functional Food),
Yuyu Pharma Incorporated
(83.10 billion Korean Won [US$69.39 million]
of which 31%
was Maxmarvil), and
Samil Pharmaceutical Co., Ltd.
(94.60 billion Korean Won [US$78.99 million]
Sales increased substantially in 2018:
Bioleaders Corp reported sales of 86.07 billion Korean Won (US$71.87 million)
December of 2018.
increase of 1,031.4%
versus 2017, when the company's sales were 7.61 billion Korean Won.
This was the fourth straight year of sales growth at Bioleaders Corp.